UniProtKB/Swiss-Prot Q9H330: Variant p.Asp9Glu

Transmembrane protein 245
Gene: TMEM245
Feedback?

Variant information Variant position:

9 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Glutamate (E) at position 9 (D9E, p.Asp9Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and acidic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs12001627 [ dbSNP | Ensembl ]

Sequence information Variant position:

9 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

879 The length of the canonical sequence.
Location on the sequence:

MADGGGPK D APSLRSSPGPAPRVPRAVGP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MADGGGPKDAPSLRSSPGPAPRVPRAVGP

Mouse                         MADRGGPAEAPSPRGSPRPESRAPRTVGP

Rat                           MADRGGPAEEPSPRGSPRSEPRVPRTAGP

Bovine                        MADDGGPEEALSPRGSPSRVPRVQRPVGA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Initiator methionine	1 – 1	Removed
Chain	2 – 879	Transmembrane protein 245
Region	1 – 36	Disordered
Modified residue	2 – 2	N-acetylalanine
Modified residue	12 – 12	Phosphoserine
Modified residue	16 – 16	Phosphoserine
Alternative sequence	1 – 448	Missing. In isoform 3.

Literature citations
Cloning, genomic organization and expression of a putative human transmembrane protein related to the Caenorhabditis elegans M01F1.4 gene.
Chadwick B.P.; Gill S.; Leyne M.; Mull J.; Liebert C.B.; Robbins C.M.; Pinkett H.W.; Makalowska I.; Maayan C.; Blumenfeld A.; Axelrod F.B.; Brownstein M.; Slaugenhaupt S.A.;
Gene 240:67-73(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); TISSUE SPECIFICITY; VARIANT GLU-9;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.